
REVVITY SIGNALS SOFTWARE, INC.
Revvity Signals Software’s advanced analytics and services solutions for Clinical Development help the world’s leading biopharmaceutical, medical device and diagnostics manufactures discover new therapeutics faster by streamlining clinical operations, transforming risk into safety and enabling actionable decisions that can lead to better health outcomes.
CONTACT INFORMATION
Revvity Signals Software, Inc.
940 Winter St
Waltham, MA 02451
UNITED STATES
Phone: 203 925-4602
BROCHURES
- An End-To-End Clinical Data Science Platform
- Risk-Based Monitoring
- A Better Outcome For Your Clinical Trials
- Clinical Analytics Solutions To Unify Your Data
- Diving Into Data From Population To Subject
- Revvity Signals Software Solutions For Pharmacovigilance And Drug Safety
- Revvity Signals Software Signals™ Line Listing Review
- Solutions For Clinical Data Review
- Data Access For Informed Patient Stratification
- Signals™ Medical Review Solution
- Clinical Data Review Analytics Solution
FEATURED ARTICLES
-
To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.
-
Read on as authors explore accessing real-time clinical trial data for proactive study management, using adverse event data to enhance safety and performance, and tools to improve design.
-
Learn how to create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.
-
To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.
-
Clinical trials can expose both predicted and unexpected safety signals. Surveillance must therefore look beyond expected adverse events to detect possible safety signals.
-
In a recent webinar, experts from Revvity Signals Software explored how solutions like its TIBCO Spotfire platform enable better, more streamlined clinical studies.
-
For medical monitors, the problem with off-the-shelf analytics tools is the lack of tailoring for medical review needs. The right data visualization tool can help medical monitors to tailor and improve their data review processes and enhance their ability to identify safety signals both quickly and surely.
-
A pharmaceutical company was looking to deploy a software solution for a small R&D group. See how an enterprise-class visualization and analytics platform enabled maximized understanding of research data.
-
Watch how Signals Line Listing Review helps clinical study teams review, query, and track the status of their line listings in a collaborative, centralized, and scalable environment.
-
See how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.
-
Master how a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.
-
Reasoning for physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient: quickly detecting safety signals and speeding time to submission.
-
Learn about the challenges for Sponsors and CROs when integrating a vast array of data sources, typical relational database structures and why they don’t work for clinical analytics, as well as the ideal clinical data aggregation solutions for continuous, automatic data consolidation.
-
To enable the completion of clinical trials as safely, efficiently, and quickly as possible, Revvity Signals Software’s clinical solutions streamline trial data visualization and analysis with real-time access to data in all phases of development.
-
How to identify, hire, and empower a modern medical monitor to help your next study proceed toward submission more productively, and with greater data integrity, than ever before.
-
Learn how a $23 billion publicly-held global specialty pharmaceutical company leveraged a software application to strike balance among its clinical studies portfolio, resources, and budget.
-
Exploratory data analysis is performed at different levels in the Novartis research and development environment. By implementing a solution that creates a workflow for exploratory clinical safety data analysis, they have access to interactive graphical data exploration that provides an efficient, powerful, and flexible tool to improve both detection and systematic assessment of safety signals.
-
Overcoming the many known barriers to adopting and implementing an RBM program.
-
What to consider when making this important strategic decision.
-
What is the medical monitor's role in the latest ICH E6 (r2) guidance and how to get them to adopt technology that will help them experience tangible efficiency and quality gains.